» Articles » PMID: 12472180

Production and Characterization of an Anti-idiotypic Single Chain Fv That Recognizes an Anti-DNA Antibody

Overview
Journal Immunol Invest
Publisher Informa Healthcare
Date 2002 Dec 11
PMID 12472180
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

A well-characterized recombinant anti-idiotype to an anti-DNA antibody can be useful for studies of the regulation of anti-DNA-producing B cells. Using a hybridoma technique, a monoclonal anti-idiotypic antibody, designated O2F3, was obtained, and its scFv gene was constructed. O2F3 single chain Fv (scFv) was produced against an idiotope of a monoclonal anti-DNA antibody, 3D8, that was obtained from an autoimmune-prone mouse, MRL-lpr/lpr. Here we describe the production and in vitro characterization of the O2F3 scFv, and compare it with its parent monoclonal antibody, O2F3 IgM. To characterize O2F3 scFv and O2F3 IgM, we generated recombinant 3D8 fragments, including 3D8 scFv, 3D8 VH, and 3D8 VL, that were used as antigens in several assays. ELISA and Western blot analysis showed that both O2F3 scFv and O2F3 IgM recognized a conformational determinant formed by the association of the variable region heavy and light chains of the 3D8 antibody, suggesting that O2F3 scFv retained a similar binding pattern to its parent O2F3 antibody. The idiotope recognized by O2F3 was shown by competitive ELISA to be outside of the DNA binding site of the 3D8 antibody. This characterized O2F3 scFv could be applied for the regulation of anti-DNA antibody production and the manipulation of recombinant antibody-based proteins to which toxins, enzymes, and chemical agents can be connected.

Citing Articles

Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA Viruses.

Luong Q, Hoang P, Ho P, Ayun R, Lee T, Lee S Int J Mol Sci. 2025; 26(4).

PMID: 40003946 PMC: 11855616. DOI: 10.3390/ijms26041481.


A synergistic therapy against influenza virus A/H1N1/PR8 by a HA1 specific neutralizing single-domain V and an RNA hydrolyzing scFv.

Hoang P, Luong Q, Ayun R, Lee Y, Oh K, Kim T Front Microbiol. 2024; 15:1355599.

PMID: 38706966 PMC: 11066198. DOI: 10.3389/fmicb.2024.1355599.


An RNA-hydrolyzing recombinant minibody prevents both influenza A virus and coronavirus in co-infection models.

Luong Q, Hoang P, Lee Y, Ayun R, Na K, Park S Sci Rep. 2024; 14(1):8472.

PMID: 38605110 PMC: 11009316. DOI: 10.1038/s41598-024-52810-0.


A Novel Approach of Antiviral Drugs Targeting Viral Genomes.

Hoang P, Luong Q, Ayun R, Lee Y, Vo T, Kim T Microorganisms. 2022; 10(8).

PMID: 36013970 PMC: 9414836. DOI: 10.3390/microorganisms10081552.


A Therapeutically Active Minibody Exhibits an Antiviral Activity in Oseltamivir-Resistant Influenza-Infected Mice via Direct Hydrolysis of Viral RNAs.

Lee Y, Hoang P, Kim D, Ayun R, Luong Q, Na K Viruses. 2022; 14(5).

PMID: 35632846 PMC: 9146509. DOI: 10.3390/v14051105.